Reinsurance provider RenaissanceRe (NYSE: RNR) will be reporting earnings this Wednesday after market close. Here’s what to look for.
RenaissanceRe beat analysts’ revenue expectations by 14.4% last quarter, reporting revenues of $3.47 billion, up 33.5% year on year. It was a mixed quarter for the company, with an impressive beat of analysts’ net premiums earned estimates but a significant miss of analysts’ EPS estimates.
Is RenaissanceRe a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting RenaissanceRe’s revenue to grow 4.3% year on year to $2.95 billion, slowing from the 52.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $9.78 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. RenaissanceRe has missed Wall Street’s revenue estimates five times over the last two years.
Looking at RenaissanceRe’s peers in the insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Progressive delivered year-on-year revenue growth of 21.3%, beating analysts’ expectations by 1.4%, and Travelers reported revenues up 7.3%, in line with consensus estimates. Progressive traded up 2.2% following the results while Travelers was also up 5.5%.
Read our full analysis of Progressive’s results here and Travelers’s results here.
Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.2% on average over the last month. RenaissanceRe is down 5.3% during the same time and is heading into earnings with an average analyst price target of $280.09 (compared to the current share price of $231.95).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
